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CD8H cytotoxic Τ cell (CTL) clones with specificity for
defined minor and major histocompatibility (H) antigens
were used to monitor antigen presentation in human
cytomegalovirus (HCMV)-infected skin fibroblasts At
the immediate early stage of virus replication antigen
presentation was intact, but was abolished dunng the
early and late phase Lack of CTL recognition was not
selective for certain antigens but was associated with
decreased steady State levels of nascent MHC class I
complexes and unassembled MHC class I heavy chains,
whereas free /?2-microglobulin remained abundant
HCMV also affected the stability of both immature
endoglycosidase Η (Endo H)-sensitive and mature Endo
H-resistant MHC class I molecules, suggesting that the
virus interferes with antigen presentation at more than
one step during maturation of the MHC class I complex
The action of interferon-y (IFN-y) and tumour necrosis
factor-α (TNF-a) lifted the block of MHC class I
complex formation by stimulating synthesis, assembly
and stability of MHC class I molecules This resulted in
restored antigen presentation provided that cells were
exposed to the factors before HCMV infection Because
few MHC molecules suffice for CTL recognition these
cytokines compensated for the negative viral effect on
the antigen presentation function Nevertheless, the viral
interference with MHC class I complex formation was
still active The data imply that specific cytokines limit
the immune evasion potential of HCMV from CD8+ Τ
lymphocyte control
Introduction
CD8+ Τ lymphocytes recogmze major histocompdübihty
complex (MHC) class I molecules that are formed as
heteiotnmenc complexes consisting of a highly poly-
morphic glycoprotein heavy chain, d noncovalently
lmked nonpolymorphic hght cham protem, ß2-
microglobulm (/?2m), and a shorl peptide denved from
antigemc protems (Townsend & Bodmer, 1989,
Rotzschke et al, 1990) After mfecüon with virus,
processmg of viral antigens requires protem degraddtion
by cytoplasmic protenidse mto pepüdes (Kelly et al,
1991, Martmez & Monaco, 1991, Ortiz-Navai rete et al,
1991) which are subsequently translocated mto the
endoplasmic reticul am (ER) by ATP-dependent peptide
transporters of the ABC family (Powis et al, 1991, Spies
et al, 1990) or by mechdmsms mdependent of ATP
(Levy et al, 1991) In this compartment, the assembly of
tnmolecular MHC class I complexes mvolves foldmg the
MHC class I heavy cham (Townsend et al, 1990),
transient interaction with chapeionms (Rajagopdlan &
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Brenner, ] 994) and peptide transporters (Ortmann et al,
1994, Suh et al, 1994), stable association with ß2m (Kvist
& Hamann, 1990), and binding of the antigemc peptide
that IS held m the polymorphic peptide bmdmg groove
MHC class I molecules lackmg peptide display a different
conformation and are deficient with respect to surface
transport and stability (Hsu et al, 1991, Lie et al, 1990)
Like viral antigens recogmzed by virus-specific cytotoxic
Τ lymphocytes (CTL), mmor Η (mH) antigens are
pepüdes and elicit MHC class I-restncted Τ cell responses
(Goulmy et al ,1977, De Bueger et al, 1992) Thus, like
major histocompatibility antigens, mH antigens also
repiesent senous barners for successful organ and bone
nurrow transpknts between mdividuals
Human cytomegalovirus (HCMV) is a member of the
herpesvirus family and establishes both acute and chronic
infections Pnmary mfecüon is followed by lifelong
persistence in a latent State from which reactivation can
occur While mfecüon of the immunocompetent host is
usually asymptomatic, HCMV causes severe and fatdl
disease in immunocompromised mdividuals such as
organ transplant recipients or AIDS patients (Drew &
Mintz, 1984, Ho, 1982) In organ and bone marrow
recipients CMV mfecüon is also a major problem in graft
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rejecüon and graft-versus-host disease (Meyers et al,
1986, Miller et al, 1986) Cell transfer expenments as
well as studies with recombmant vaccmes expressing a
class I restncted epitope (Reddehase et al, 1987)
demonstrated that CD8H Τ lymphocytes play an essential
role m the host defence against munne cytomegalovirus
(MCMV) and mediale protective immumty Adoptive
immunotherapy of CMV mfections in humans with
antiviral MHC class I-restncted CD8+ Τ lymphocytes
supports this notion (Riddell et al, 1992)
Previous studies demonstrated that munne cytomegalo-
virus can mterfere with the MHC class I antigen
presentation pathway by an early (E) gene funclion (Del
Val et al, 1989) MCMV prevents presentation of
peptides denved from immediate early (lE)-expressed
protems by blocking the transport of the pepüde loaded
MHC class I complexes through the Golgi compartment
(Del Val et al, 1992) This ability of MCMV to mhibit
antigen presentation and to evade CD8^ Τ cell-mediated
immune control IS overcome by the action of mterferon-
y (IFN-y) in vitro as well as in vivo (Hengel et al, 1994)
Like MCMV, HCMV is able to decrease MHC class I
expression (Barnes & Grundy, 1992) Beersma et al
(1993) reported that nascent MHC class 1 molecules are
unstable m infected cells. Although HCMV-mfected cells
were deficient in presentation of an externally loaded
synthetic pepüde to CTL (Warren et al, 1994), the
functional consequences of this mterference with antigen
presentation of endogenously processed pepüde antigens
are not clear The mterference of HCMV with CD8+ Τ
cell recognition was considered to be specific for ΪΕ
antigen (Gilbert et al, 1993) despite the fact that HCMV-
IE antigen-specific CD8+ Τ cell responses can be ehcited
in vitro (Borysiewicz et al, 1988)
Here we report that mfecüon of skm fibroblasts with
HCMV, which leads to a loss of MHC class I complex
formaüon and surface expression due lo an Ε gene
function of the virus, is paralleled by the absence of
presentation of constitutively expressed minor or major
Η antigens The viral mterference showed no antigen
selectivity The block of antigen presentation was
overcome by pretreatment of cells with IFN-y or
tumour necrosis faclor (TNF-α) Although these cyto-
kines can also have direct antiviral activiües (Lucin et al,
1994) the effect upon antigen presentation is due to a
strong increase of the steady State levels of MHC class I
complexes, thereby restormg pepüde presentation while
the viral Ε gene mechanism was still acüve
Methods
Cells The human foreskin fibroblast cell lines VH3 and VH7 were
estabhshed in pnmary culture after Standard procedures by mincmg the
skm and subsequent stirnng in prewarmed trypsin (Wiedbrauk &
Johnston, 1992) Recovered fibroblasts were passaged in DMEM
supplemented with 10% FCS, penicillm, streptomycin and 2 mM-
glutamine and used between culture passages 6 to 12
Virus and mfetlion ionditions Virus Stocks were prepared by
propagating HCMV strain AD 169 (a gift of Μ Mach, Erlangen, FRG)
in fetal human lung fibroblasts (passages 6 to 20) grown in DMEM
supplemented with 10% FCS Infectious supernatants were harvested
when 100% of the cells showed a cytopathogenic effect The tilres of
virus Stocks were determined by Standard plaque assays after
centnfugaüon at 800 g for 30 min and had an mfectivity of 5 χ 106 to
3 χ 10' ρ f u /ml For infecüons, subconfluent monolayers of VH cells
were mcubated with HCMV at the m ο ι indicated and cultures were
centnfuged at 800 g for 30 mm to enhance the efhuency by a factor of
10 to 20 In all expenments, control settmgs showed more than 97 % of
cells positive for HCMV Ε gene expression in immunofluorescence
microscopy (Gleaves et al, 1984) Selective expression of HCMV IE
gene products was achieved by infection of cells with HCMV in the
presence of cycloheximide (50 μg/ml), which was replaced 4 h later by
actinomycin D (5 μg/ml) followed by incubation for 7 h before the cells
were further analysed Late phase gene expression was prevented by the
use of phosphonoaceüc acid (PAA, 250 μg/ml), which arrests CMV-
mfected cells in the Ε phase
Reagents and antibodies Recombmant human IFN-y and TNF-a
were obtained from Bochrmger Mannheim, and human IFN-α was
purchased from Paesel and Lorei (Frankfuit/Main, Germany) The
following monoclonal antibodies (MAbs) were used W6/32 (anti-
HLA class, I complexes) (ATCC HB 95), BB7 2 (anti HLA-A2) (ATCC
HB 82), BBM 1 (anti-human ß2m) (ATCC HB 28), anti-HLA A,B,C
heavy chain (Olympus) (Bushkm et al, 1986), anti-actin (Boehringer
Mannheim), anti-HCMV early nuclear antigen (Du Pont NEN), anti-
HCMV late nuclear antigen (Du Pont NEN), anti-ICAM-1
(Immunotech), anti-transfernn receptor (Oncogene Science), and anti-
CD44 (Immunotech) Polyclonal rabbit anü-mouse IgG was from
Dianova
Flow cytometry Isolated VH cells were pre-incubated in 5% goat
serum and then stained with MAbs Bound antibodies were visuahzed
by addition of fluorescein-conjugated goal anti mouse isotype-specific
(Medac) antibodies As a negative control cells were mcubated with the
sccond antibody alone Α total of 101 cells was analysed for each
fluorescence profile on a FACScan IV (Becton Dickinson)
Metabolie labelling, immunopteupitation and endoglytosidase Ii
treatment Cells were labelled with [•"SJmethionmc (1200 Ci/mmol,
Amersham) at a concentration of 500 μ θ / m l as desenbed previously
(Del Val et al, 1992) In bnef, anti-actin and rabbit anti-mouse IgG
were used to remove actin molecules Subsequently, quantitative
precipitations were performed sequentially with protem G punfied
preparations of MAb W6/32, followed by BBM1 and anti-HLA
A,B,C To ensure quantitative retneval of immune complexes, the
lysates were mcubated twice more with Piotem A-Sepharose (Phar-
macia) before addition of the next MAb Immune complexes were
mock treated or digested with 2 mU of endoglycosidase Η (Endo H)
(Boehringer Mannheim) overmght at 37 °C, eluted with sample buffer,
and analysed by 10-15% polyacrylamide gradient gel electrophoresis
The gels were treated with En^Hance (Du Pont NEN), dned, and
exposed to X-Omat AR films at - 7 0 °C for 1-7 days
Cytolytic assays The generation and maintenance of the CD84 CTL
clones used in this study was desenbed in detail earher (De Bueger et
al ,1992, Van Eis et al, 1992) The CTL clone 3E7 is allo-A2 specific,
theclone IR35 specific for the male H-Y antigen is HLA-A2 resliictcd,
and the clone 5HO11 recognizing the HA 3 mH antigen is HLA-Al
restneted In bnel, the CFL clones were eultured in RPM1 1640
supplemented with antibiotics, 15 % pooled human serum and 20 U/ml
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rIL-2, and they were expanded by weekly restimulation with irradiated
EBV-immortalized BLCL plus freshly isolated PMNC from random
donors. Cryopreserved CTL were thawed for immediate iisage as
effector cells in 51Cr-release assays or kept for 2-4 days with 20 U/ml
rIL-2 before use. After washing and treatment with trypsin, VH cells
were labelled with 5 1Cr for 1 h. The viability of cells was determined by
trypan blue exclusion and suspended targets were used at 1000 cells per
well in a Standard 4 h 51Cr-release assay. In all experiments, effector to
target (E/T) ratios ranged from 20:1 to 0-16.1. Spontaneous 5 1Cr
release in the experiments given did not exceed 30 % of the maximal
release values measured in the presence of 1 % Triton X-100.
Results
HCMV affects CD8+ Τ cell recognition of major and
minor histocompatibility antigens
The recognition of different viral epitopes by CD8+ CTL
is inhibited by HCMV functions. Since the recognition of
individual antigens is affected to a different extent, the
virus function appeared to be selective for IE antigen,
but independent of MHC expression (Gilbert et ah,
1993). Such features complicate the analysis of inhibitory
functions when HCMV-specific CTL are used to assess
the antigen presentation function during infection. We
took advantage of the detection of constitutively expres-
sed cellular peptides by MHC class I-restricted CTL. The
HLA-A2-restricted human mH antigen H-Y and the
HLA-Al-restricted antigen HA-3 are expressed by
human foreskin fibroblast cells (HFF) (Goulmy, 1988;
De Bueger et ah, 1992). HFF cells from randomly
selected donors were prescreened for HLA A-2 ex-
pression and antigen presentation to peptide-specific
CTL clones. The HFF cell lines VH3 and VH7 were
identified as suitable targets for H-Y and HA-3 as well as
for HLA-A2 specific CTL clones. To follow presentation
of mH peptides and of HLA-A2 during permissive
HCMV infection, VH cells were infected at an m.o.i. of
15 and tested throughout the HCMV replication cycle.
As shown in Fig. 1, after viral gene expression for 12 h,
HLA-A2 and mH peptide antigens could be recognized
by the respective CTLs. However, later stages of HCMV
infection were associated with inhibited presentation of
both H-Y and HA-3 peptide, and with delayed kinetics
the recognition of HLA-A2 molecules was also abolished
at 96 h post-infection (p.i.) (Fig. 1). Impaired CTL
recognition of the HLA class I-dependent antigens after
HCMV infection was observed for both VH3 and VH7
Mock 12 h 24 h 72 h 96 h p.i.
anti-HLA-A2 H-Y
anti-HLA-Al HA-3
anti-HLA-A2 (allo)
0 8 20
E/T ratio
Fig. 1. Effect of HCMV infection on CD8+ CTL recognition of minor and major histocompatibility antigens. mH antigen H-Y- and
HA-3-expressing HLA-A2+ fibroblasts (VH7) were infected with CMV (m.o.i. 15) at the time points mdicated before cells were labelled
for 60 min with 5 1Cr and tested in a 4 h Standard Cr-release assay with graded numbers of effector cells. The effectors were CTL clone
1R35 specific for H-Y antigen (upper panels, ®). CTL clone 5HO11 specific for HA-3 (middle, H), and CTL clone 3E7 that recognizes
HLA-A2 as an allo-antigen (lower panels, A).
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cells, and occurred with identical kinetics at all virus
doses tested (m.o.i. 3, 15 and 75) without affecting cell
viability and spontaneous 5 1Cr release (data not shown).
Thus HCMV interferes with the recognition of en-
dogenous MHC class I antigens in an antigen-inde-
pendent manner.
In permissively infected cells, CMV gene expression is
regulated in a cascade fashion characteristic for herpes-
viruses. Metabolie inhibitors of viral gene expression can
be used to separate the different phases of infection, i.e.
the immediate early (IE), early (E) and late (L) phase. In
order to assign interference of the virus with HLA class
I antigen recognition to a distinet phase of HCMV gene
expression, cells were infected (as described in Methods)
in the presence of cycloheximide, an inhibitor of protein
synthesis; this was replaced after 4 h by the inhibitor of
transcription actinomyein D, resulting in a restriction of
HCMV gene expression to the IE phase. Under these
conditions of selective IE expression recognition of VH
fibroblasts by the CTL clones 12 h p.i. was actually
augmented compared to mock controls (data not shown).
When an arrest of the Ε phase was achieved by infection
of cells in the presence of PAA, which blocks viral DNA
replication and the subsequent expression of late phase
genes, lysis by H-Y- and HA-3-specific CTL was
completely abolished at 72 h p.i. In contrast to per-
missively infected cells showing late gene expression,
HLA-A2-specific CTL still recognized these targets to
some extent (data not shown). These experiments
confirmed a previous observation that the viral gene(s)
inhibiting CTL recognition are already being expressed
in the Ε phase of produetive HCMV infection (Warren et
al., 1994).
An early gene funetion of HCMV selectively reduces
MHC class I expression
Cytomegaloviruses, both mouse and human, are known
to interfere with MHC class I molecule expression. In the
case of MCMV, retention of nascent correctly assembled
MHC class I complexes in the ER/cw-Golgi com-
partment during the viral Ε phase results initially in
inhibited presentation of newly synthesized antigens, and
later on in a general reduetion of MHC class I molecules
at the cell surface (Del Val et al., 1992). HCMV was
reported to destabilize MHC class I complexes within
24-40 h without affecting class I heavy chain mRNA
levels (Beersma et al., 1993; Yamashita et al., 1993;
Browne et al., 1990). To follow the fate of resident MHC
class I molecules during the course of HCMV infection in
VH cells, expression of MHC class I molecules was tested
in parallel with the adhesion molecules ICAM-1 (CD54),
pgp-1 (CD44), and the transferrin reeeptor (CD71). As
assessed by cytofluorometric analysis, the surface den-
sities of these marker molecules remained essentially
unaffected during infection. As reported by Downes &
Grundy (1993), levels of ICAM-1 molecules were even
slightly increased during the course of permissive
infection (data not shown). In contrast, the density of
HLA class I complexes conünuously decreased during
HCMV infection resulting in a loss of about 90 % of the
molecules at 96 h p.i. Next, sequential and quantitative
immunopreeipitation experiments after [35S]methionine
labelling of HCMV-infected VH cells were performed to
study the fate of nascent class I molecules in HCMV-
infected VH cells. The MAb W6/32 recognizes only ß2m-
assembled HLA molecules. Using this antibody, under
IE conditions (data not shown) or 12 h after HCMV
infection, a slight increase of steady State levels of
complexed class I molecules was seen that was followed
by a dramatic reduetion in recovered class I complexes at
72 h p.i. and later stages of infection (Fig. 2a).
Subsequent preeipitation of free /?2m revealed an increa-
sed expression of this molecule (Fig. 2b). The abundance
of isolated HLA class I heavy chains was reduced,
although not to the extent of jß2m-assembled class I
heavy chains (Fig. 2c). Transferrin reeeptor molecules
were expressed in constant amounts (data not shown).
Restriction of HCMV gene expression to the Ε phase by
PAA treatment was also associated with significantly
reduced amounts of HLA class I complexes, although
under these conditions the viral effect was less pro-
nounced than in the absence of PAA, when cells were
allowed to express late phase genes (vide infra, Fig. 4 a,
lane 3). Although oecurring in VH cells with delayed
kinetics, these fmdings revealed the HCMV-MHC class
I interaction that speeifieally affects the stability of the
association of HLA heavy chains with ß2m (Beersma
et al., 1993) and differs from that described for MCMV
(Del Val et al., 1992). As found for MCMV, the viral
mechanism is expressed as an Ε gene(s) funetion and
results in deficient antigen presentation to CD8+ Τ
lymphocytes.
Cytokines restore antigen presentation to CD8^ CTL
during HCMV infection
HCMV infection in vitro impairs the ability of infected
cells to present antigen via MHC class I molecules.
However, in vivo CD8+ Τ lymphocytes are effective in the
control of HCMV (Riddell et al., 1992). Lack of antigen
presentation in the MHC class I pathway is not
compatible with this finding. Therefore, we suspected
that the block of antigen presentation by HCMV-
infected cells in vitro does not reflect the Situation in vivo.
Distinet soluble factors can modulate several steps in the
intracellular pathway of antigen processing and pres-
entation (Wong et al., 1983; Klar & Hämmerüng, 1989;
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(a) W6/32
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Fig. 2. Steady State lcvels of MHC class I complexcs, of free /?2m and of free MHC heavy chains dunng HCM V infection After HCM V
infection (m o.i 15) of VH cells for the time indicated, metabohc labelling with [35S]methiomne was performed for 90 min. The cell
lysates were immunoprecipitated sequentially, first with MAb W6/32 (a) specific for assembled MHC class I complexes, then with MAb
BBM1 (6) reacting with ß2m and finally with an anti-heavy chain MAb (c). Precipitates were separated on 12-15% gradient
SDS-PAGE gels.
Ortiz-Navarrete et al, 1991). Το test whether the HCMV
Ε gene effect can be lifted by such cytokines, IFN-y was
investigated as a candidate. VH cells infected for 72 h
were exposed to 500 U IFN-y/ml for different periods of
time before infection and targets were analysed for
antigen presentation. As shown in Fig. 3 (α), IFN-y
rescued presentation of both HY and HLA-A2 antigen
but with different kinetics. While the addition of IFN-y
at the same time as infection had no effect, pre-incubation
for 24 h sufficed to restore HLA-A2 recognition while
the HLA-A2-restricted presentation function to H-Y-
specific CTL was not improved. Pretreatment for 48 h,
however, fully restored presentation of both antigens
compared to iminfected controls. This action of IFN-y
followed a dose-dependent relationship (Fig. 3 b). Pres-
entation of HLA-A2 responded at low concentrations of
the cytokine while optimal presentation of mH peptides
required 500 U/ml of the cytokine.
The ability of IFN-y to restore presentation of HCMV-
infected cells prompted us to test TNF-α and type I
Interferons (α, β), which have been reported to increase
MHC class I expression (Collins et al, 1986; Pestka et
al, 1987; Pfitzenmaier ei al, 1987). Fig. 3(c) shows that
these factors, like IFN-y, also restore MHC class I-
dependent antigen presentation of HCMV-infected cells
when pre-incubated for 48 h. In addition, TNF-α can
cooperate in mH antigen presentation with IFN-y (Fig.
3ä). Finally, conditioned supernatants from HCMV-
infected fibroblast cultures stimulate the presentation of
mH antigens after pre-incubation of target cells and this
effect was sensitive to anti-IFN-/? antibodies (data not
shown). From these experiments two conclusions were
drawn: first, IFN-y, TNF-α and type I Interferons are
able to compensate for the negative effect of HCMV on
MHC class I presentation, and, second, that these
cytokines cannot restore defective antigen presentation
in cells that are already infected.
Overexpression of MHC class I molecules by IFN-γ
provides ternary complexes for antigen presentation
IFN-y displays multiple effects on both viral as well as
cellular genes (Pestka et al., 1987). It is able to enhance
the expression of MHC class I and ß2m genes (Wong et
al., 1983). In MHC class I-deficient tumour cells that
constitutively express unassembled heavy chains (Klar &
Hämmerling, 1989; Sibille et al, 1992) IFN-y stimulates
direct association of MHC class I heavy chains with /?2m.
To decide by which mechanism IFN-y lifts the negative
viral effect on MHC class I complex formation, VH cells
were pretreated with cytokines and infected for 72 h.
Cells were metabolically labelled for 90 min and cellular
lysates were sequentially subjected to quantitative
immunoprecipitations by the MAb W6/32 which selec-
tively precipitates assembled class I complexes. Fig. 4(α)
shows a strong increase in steady State levels of ß2m-
associated heavy chains in HCMV-infected cells pre-
incubated with either IFN-y, TNF-α or type I IFN,
compared to untreated cells. The amount of recovered
MHC class I complexes, however, did not reach the level
for cytokine-conditioned mock-infected VH cells as
indicated by the fainter /?2m bands of MHC complexes in
HCMV-infected samples, showing that the inhibitory Ε
gene function was still active. The pattern of viral
proteins induced after IFN-y pretreatment showed no
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Fig 3 For legend see opposite
detectable differences when analysed with polyclonal
human sera (data not shown) Immunoprecipitaüon of
the viral 72 kDa early prolem with a Μ Ab (Fig Ab)
revealed a moderate Stimulation by mterferons of HCMV
early gene expression In addition, the 68 kDa late
protem was present in HCMV-mfected cells exposed to
INF-y or TNF-α (Fig 4c), suggesting that the activity on
MHC class I gene expression and not an effect on viral
genes IS responsible for the restoration of antigen
presentation
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Fig 3 (a) Kinetics of restoraüon by cytokines of raH antigen and HLA-A2 presentation in HCMV-infected cells After vanous penods
of pretrealment with IFN-y (500 U/ml), VH3 cells were infected with HCMV (m ο ι 15) for 72 h before 51Cr-release assay at the E/T
ratios mdicated IFN-y was present until cells were harvested for the CTL assay A, CTL clone 3E7 recogmzing HLA-A2 allo-antigen,
· , CTL clonc 1R35 speofic for HLA-A2 H-Y (b) For 48 h before HCMV infection (m ο ι 15), VH3 cells were exposed to titrated
concentralions of IFN-y, 72 h after infection, cells were tested with anti-HLA-A2 (A) dnd anti-HLA-A2 H-Y ( β ) CTL (c) VH7
flbroblasts were pie-mcubated with 500 U IFN-a/ml or 10 ng TNF-a/ml for 48 h before infection with HCMV (m ο ι 15) in the
piesence of cytokines for 72 h A, CTL clone 3E7 recogmzing HLA-A2 dllo-antigen, · , CTL clone 1R35 specific for HLA-A2 H-Y,
• , CTL clone 5HO11 specific for HLA-Al HA3 Targets were assayed with CTL at the E/T ratios indicated (d) IFN-y and/or TNF-
α were added to VH7 cells 48 h before HCMV infection (m ο ι 15) A, CTL clone 3E7 recogmzing HLA-A2 allo-antigen, · , CTL
clone 1R35 specific for HLA-A2 H-Y, R. CTL clone 5HO11 specific for HLA-Al HA3
Stabihzation of MHC class I molecules by IFN-γ
The failure to present endogenous peptide antigens
during HCMV infection IS associated with a down-
regulation of assembled trimolecular class I complexes.
IFN-y increases steady State levels of MHC class I
complexes in HCMV-infected cells. In order to analyse
whether IFN-y affected the half-life of nascent class I
complexes during HCMV infection, pulse-chase experi-
ments were performed. Class I complexes preeipitated by
MAb W6/32 were subjeeted to Endo Η digestion. This
enzyme preferentially cleaves immature TV-linked ohgo-
sacchandes characteristic of glycoproteins that have not
reached the medial-Go\gi complex (Kobata, 1979).
Further processing of the oligosacchande chain by
enzymes located in the medial-Golgi compartment
renders the glycan strueture resistant to Endo Η cleavage
and thus characterizes mature class I molecules
(Kornfeld & Kornfeld, 1985). After a pulse with
[35S]methionine foi 25 min, a significant proportion of
the class I molecules synthesized in mock-infected cells
and a smaller number in HCMV-infected cells already
exhibited Endo Η resistance. These molecules were
represented by several slower migrating heavy chain
bands while Endo H-susceptible class I glycoproteins
showed a faster mobility resulting from Endo Η cleavage
(Fig. 5, left). After a 30 min chase nearly all class I
complexes lost sensitivity to Endo Η digestion in mock-
treated VH cells, while class I molecules in HCMV-
infected cells were processed to Endo H-resistant forms
with shghtly delayed kinetics. While in mock-infected
VH cells a significant proportion of class I complexes
was still stable after 270 min chase, the bulk of class I
complexes in HCMV-infected cells disappeared withm
90 min, meluding even those molecules that had matured
to an Endo H-resistant phenotype. Compared to un-
treated cells, a strong induetion of nascent class I
complexes was noted in IFN-y-treated cells (Fig. 5, right)
resulting in an overexposure of this part of the
autoradiograph. Notably, the majority of labelled class I
molecules in HCMV-infected VH cells was still present
after 270 mm chase as in mock-mfected cells. Α shorter
exposure of the film showed an almost comparable
strong band for MHC class I heavy chains (data not
shown). This observation indicates that IFN-y can
protect MHC class I complexes from destabilization by
HCMV gene funetions. The restoration of antigen
presentation therefore consists of two events. The first is
the enhanced expression of class I molecules. Secondly,
MHC molecules loaded with peptides escape the viral
interference, maintain stability as ternary complexes, and
are transported to the cell surface.
Discussion
Previous studies have demonstrated that MHC class I
molecules are downregulated by HCMV without re-
duemg the mRNA levels of MHC class I gene produets
(Barnes & Grundy, 1992; Browne et αι., 1990; Warren et
al, 1994). This viral effect is associated with both a
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Fig 4 MHC class I complex formaüon in the
presence of PAA, in cytokine pretreated HCMV-
mfcctod VH3 cells and in cytokine pretredted
mock infectcd VH3 cells Cells were exposed to
IFN y, IFN-α or TNF-a at the concentraüons
mdicdted for 48 h bcfore HCMV infection
(m ο ι 15) 72 h dfter infection cells were meta-
bolically labelled with [' S]methionme for 90 min
lysed and immunoprecipitated with an anti-actin
MAb followed by MAb W6/32 (a) W6/32
precipitates were separatcd on 12-15%
SDS PAGE gradicnt gels Transition of infection
from Ε to late gene expression was prevented by
the continuous presence of PAA (250 μg/ml)
(b c) Cytokine pretreated HCMV infected cells
express unchanged levels of HCMV 72 kDa Ε
protein (b) and 68 kDd Ute protein (c) Cytokine
treatment HCMV infection and meldbolic label-
ling were performed as desenbed in Methods
HCMV proteins were immunoprccipitated
sequentially by spccific MAbs and precipitates
subjeeted to gel electrophoresis on 15% SDS-
PAGE gels
Mock HCMV-infected Mock HCMV infected
No IFN γ 500 U IFN γ
kDa
46 —
10 30 90 270 0 10 30 90 270 0 10 30 90 270 0 10 30 90 270 min (chase)
jjjpli
Fig 5 Stabili7dtion of MHC class I complexes in IFN-y pretreated HCMV infected cells Mock-infecfed or HCMV-infccted VH cells
weie pie ineubdted with 500 U IFN y/ml for 48 h as mdicated Cells were pulse-ldbelled with [''SJmethioninc for 25 min dnd then
chased for the mdicated times Immunoprecipitation was performed with MAb W6/32 Before gel electrophoresis all samples were
digested with Endo Η The bands resulting from enzymatic digestion are mdicated s (for susceptible) or ι (for resistant; Only the
heavy chdin region of the autoradiogram is shown
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reduced stability of MHC class I heavy chains and
decreased steady State levels of assembled ternary MHC
class I complexes. This mechanism is thought to affect
presentation and CTL recognition of HCMV peptide
antigens. In this study, two aspects were addressed
concerning the evasion of HCMV from CD8+ Τ cell
surveillance. First, we determined the extent and kinetics
by which HCMV infection alters the endogenous peptide
presentation function of infected cells. Second, the
antagonistic influence of selected cytokines on the viral
effect was studied.
In terms of MHC class I-restricted Τ cell recognition,
different HCMV epitopes derived from nonstructural IE
and structural late antigens are differentially sensitive to
the viral effect (Gilbert et al., 1993). The apparently
selective effect on different viral antigens is thought not
to be MHC linked. However, when only HCMV-specific
CTL are used as a probe, such properties may render the
functional analysis of the effect on MHC class I
expression difficult. Therefore, we decided to analyse
HCMV-infected cells with MHC class I-restricted Τ
lymphocytes that detect not viral but cellular peptides
that are constitutively presented. We find a stringent and
general HCMV control of MHC class I antigen pres-
entation.
As observed by others (Beersma et al., 1993;
Yamashita et al., 1993) the viral Inhibition of MHC class
I complex formation is initiated during the Ε phase of
infection and is most prominent at late times of the
HCMV replication cycle. This event is paralleled by a
decrease in mH peptide recognition by CD84 CTL. The
presentation kinetics of individual peptide antigens was
different; also the recognition of allo-HLA-A2 was
susceptible to the viral effect. Α reason for the sustained
allo-reactivity could be that the CD8+ Τ cell clone 3E7
not only recognizes trimolecular HLA-A2 complexes but
also unassembled HLA-A2 heavy chains. Conversely,
restoration of antigen presentation by IFN-y and TNF-
α oecurred at lower cytokine concentrations for HLA-A2
allo-recognition compared to minor peptide recognition.
Although the oecurrence of a defect in MHC class I
complex formation caused by HCMV strain AD 169
correlated with the decrease of CDS"1 Τ cell recognition
by VH skin fibroblasts, the kinetics of this event is much
slower than reported recently (Beersma et al., 1993;
Warren et al, 1994; Yamashita et al., 1993). This
discrepancy can be explained by the properties of
different cell lypes. In human fetal lung fibroblasts Endo
Η cleavage patterns indicate that the breakdown of
MHC class I complexes oecurs primarily in a pre-Golgi
compartment. As a consequence, the exit of class I
complexes from the ER is drastically reduced, and a
more rapid loss of CD8+ Τ cell recognition is found
compared with VH cells, which are human dermal
fibroblasts (data not shown). The latter express higher
amounts of MHC class I molecules and the viral
interference not only affects Endo Η-sensitive MHC
molecules but also destabilizes more mature, Endo H-
resistant class I complexes, suggesting that the viral effect
can operate in or beyond the cw-Golgi compartment.
These differences suggest that some cell types are more
susceptible to the viral effect than others. Particular cell
types may even be constitutively resistant, which would
explain why HCMV-specific CTL are generated after
infection (Borysiewicz et al., 1988). On the other hand,
our data imply that the CD8+ Τ cell-mediated clearance
of infection in fibroblast-like cells requires the regulating
activities of cytokines like Interferons and TNF-oc. In vivo
experiments with MCMV support this idea (Hengel et
al., 1994). The mode of interference with the MHC class
I presentation pathway differs between mouse and
human CMV. While the latter reduces the stability of
class I molecules, the former has no influence on MHC
class I complex formation and stability, but prevents the
exit of peptide-charged molecules from the ER/ciy-Golgi
(Del Val et al., 1992). In addition to this Inhibition of
nascent MHC class I molecules, an independently
expressed MCMV gene function affects resident MHC
class I complexes at the cell surface (Thäle et al., 1995).
Therefore, our analysis in HCMV-infected fibroblasts
required us to determine the decrease of both nascent
and resident class I molecules. The kinetics we observed
by using CD8+ CTL clones that detect cellular peptides
does not indicate that HCMV interferes with resident
MHC class molecules before effects on nascent MHC
class I molecules are initiated.
In both HCMV and MCMV, IFN-y funetions as an
antagonist that restores antigen presentation. Recently,
the gene produet of the herpes simplex virus (HSV) IE
gene ICP 47 was identified as a viral factor that inhibits
antigen presentation to CD8+ Τ lymphocytes (York et
al., 1994) by blocking peptide transporters (Hill et al.,
1995; Früh et al., 1995). Its expression as an IE gene
produet may contribute to the finding that minor
peptide-speeifie CTL lysis is already affected at 5 h p.i.
(Kuzushima et al., 1990). It is not known whether this
effect can also be overcome by IFN-y. More than one
cytokine can rescue antigen presentation. Their mode of
action is complex, but it is a common feature that their
effect results in an increased abundance of MHC class I
complexes. Our experiments focused on MHC class I
molecule biosynthesis and complex stability. Any posi-
tive effect of the cytokines on earlier Steps like antigen
processing, ER translocation of peptides or chaperonin
expression should also increase the yield of final
processed peptide and thus contribute to higher levels of
ternary class I complexes (Klar & Hämmerling, 1989;
Sibille et al., 1992; Spies et al., 1990).
2996 Η Hengel and others
The data presented here demonstrate a block on
presentaüon of endogenous, non-viral anügens due to
HCMV Ε gene funcüons and imply that there IS also
viral mterference with the presentaüon of HCMV
antigens Expenmental evidence for Ihis was presented
by Gilbert et al (1993) who demonstrated weak CD81"
CTL recogmtion of HCMV IE-specific Τ cell hnes durmg
permissive HCMV mfection Antigen-specific mechan-
lsms, hke competition between viral peptide ligands
and weaker cellular peptides (Kuzushima et al, 1990),
and selective properties of mdividual HCMV antigens
(Gilbert et al, 1993) have been discussed in order to
explam the viral effect If the effect is mdeed dommated
by peptide competition, contmuous presentation of
certam seif peptides, retamed allo-A2 CTL recogmtion
and stable expression of MHC class I complexes should
be expected In addition, external loadmg of HCMV-
mfected fetal lung fibroblasts with syntheüc antigemc
peptide of the mfluenza virus matnx protem also failed
to sensiüze target cells for HLA-A2-restncted CTL lysis,
mdicatmg a cntical loss of class I molecules (Warren et
al, 1994)
In organ and bone marrow transplants, HCMV
mfection is associated with graft rejection and graft-
versus-host disease (Miller et al, 1986, Reddehase et al,
1987, Rubm, 1990) Here we document that presentation
is regulated by cytokmes either produced by the HCMV-
mfected cell ltself (ι e type I Interferon) or by antiviral Τ
lymphocytes (IFN-y, TNF-α) Inflammation in response
to viral mfection may represent a direct link that also
mcreases the extent of mH peptide presentation in
umnfected cells (De Bueger et al, 1992), leadmg to a
break in Τ cell tolerance, allograft rejection and graft-
versus-host disease (Krammer et al, 1984)
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